Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Marta Bognar (NPI 1336102425)

Field	Value
Entity Type	Individual
Organization	Marta Bognar
Address	700 S Enota Dr Ne
City	Gainesville
State	GA
ZIP	30501
Taxonomy	Rheumatology Physician
NPI Enumerated	April 10, 2006

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

This provider’s billing footprint is almost entirely Medicare-based: lifetime Medicare revenue is $2.3M and there is no Medicaid billing on file, so the practice is effectively single‑payer with revenue coming from Medicare patients only. That payer concentration creates exposure to Medicare reimbursement trends for infused biologics and outpatient infusion services.

Revenue is highly concentrated in three biologic drug codes: the precomputed top‑3 Medicare codes account for 61.8% of total Medicare revenue, driven by J0129 ($595K, 25.6%), J9312 ($536.3K, 23.0%), and J3262 ($306.8K, 13.2%). This concentration indicates the majority of earnings are coming from in‑office administration of high‑cost injectable biologics rather than from routine office visits or ancillary testing.

The CPT/HCPCS mix is consistent with a rheumatology practice that operates an in‑office infusion suite: multiple large revenue lines are for biologic injections (J0129, J9312, J3262, J1602, J0717, J1745) and infusion administration/chemotherapy CPTs (96365, 96413, 96415) appear in the top codes. Together these imply substantive clinical throughput for intravenous/subcutaneous biologic therapy and associated infusion labor and facility workflows.

Competitive standing varies by drug: the provider is a national high‑volume reporter for rituximab (J9312 ranks #14 of 317, 96th percentile; labeled notably above typical national volume), while J0129 ranks #166 of 1221 (86th percentile; typical, unremarkable volume) and J3262 ranks #170 of 618 (73th percentile; typical, unremarkable volume). In short, this clinician is a major national contributor for J9312 but otherwise a modest‑to‑typical participant for other biologic codes.

Outpatient management and infusion throughput are both material to the business model: 99214 generates $69.9K (3.0% of Medicare revenue) and ranks #19310 of 479517 (96th percentile; notably above typical national volume), while the infusion add‑on 96415 ranks #205 of 4959 (96th percentile; notably above typical national volume). These patterns indicate a steady volume of moderate‑complexity follow‑up visits combined with frequent extended infusion sessions.

The absence of any Medicaid revenue on file ("none below") means the provider does not participate in Medicaid billing in the available data, which concentrates payer mix risk but also simplifies revenue modeling to Medicare reimbursement schedules and biologic drug payments. This also limits in‑state competitive comparison on Medicaid metrics because there are no Medicaid claims to benchmark.

The provider has a long tenure in the NPI registry (enumerated 2006-04-10, ~20 years ago), indicating an established practice and likely embedded referral relationships; longevity aligns with the sustained Medicare biologic volumes observed.

Many ancillary services and outpatient procedures show routine but notable volumes: infusion administration (96365) ranks in the 94th percentile and several lab codes (86140, 85025, 85652) are in high national percentiles (93th, 91th, 94th respectively), reinforcing that the practice supports substantial on‑site testing and infusion operations alongside its biologic drug administration.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

47 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	18,030	$30	$595K
J9312	Injection, rituximab, 10 mg	8,510	$60	$536.3K
J3262	Injection, tocilizumab, 1 mg	61,360	$10	$306.8K
J1602	Injection, golimumab, 1 mg, for intravenous use	24,800	$10	$272.8K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	64,800	$1	$259.2K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	3,670	$30	$91.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	800	$90	$69.9K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	1,990	$30	$57.7K
J0897	Injection, denosumab, 1 mg	1,680	$20	$31.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	330	$90	$30.8K

Showing 1–10 of 47

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 47 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Marta Bognar — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

47 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	5	30	9,660	$30	$403.6K
J9312	1	10	4,620	$60	$307.4K
J1602	9	30	17,200	$10	$240.1K
J3262	5	10	45,840	$1	$233.4K
J0717	2	20	38,000	$1	$199.3K
J1745	11	30	2,160	$30	$96.6K
J0897	199	290	2,460	$20	$90.2K
Q5104	3	10	2,320	$30	$71.3K
86235	19	20	310	$20	$49.5K
96413	40	160	170	$90	$20.3K

Showing 1–10 of 47

Related Providers

Other providers that share a Tax Identification Number (TIN) with Marta Bognar, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
William Chafin	GA	Rheumatology Physician	$3.3M	$0
Taylor Mader	SC	Rheumatology Physician	$3.1M	$0
Dean Stephens	GA	Rheumatology Physician	$2.7M	$0
Charles Degenhardt	GA	Rheumatology Physician	$2.4M	$0
Paul Sutej	GA	Rheumatology Physician	$2.4M	$0
Durga Adhikari	SC	Rheumatology Physician	$2.4M	$0
Brent Flickinger	GA	Rheumatology Physician	$2.3M	$0
Kathleen Flint	SC	Rheumatology Physician	$2.3M	$0
Colin Edgerton	SC	Rheumatology Physician	$1.9M	$0
John Brittis	SC	Rheumatology Physician	$1.9M	$0

Nearby Providers

Other providers in the same ZIP code as Marta Bognar, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Northeast Georgia Medical Center, Inc.	GA	General Acute Care Hospital	$0	$112.9M
Georgia Emergency Department Services, P.C.	GA	Emergency Medicine Physician	$0	$17.9M
S.y.a.h.	GA	Urgent Care Clinic/Center	$0	$6.5M
Pediatric Associates LLP	GA	Pediatrics Physician	$0	$5M
Gainesville Radiology Group, PC	GA	Diagnostic Radiology Physician	$0	$2M
Hall County Georgia	GA	Land Ambulance	$1.6M	$0
Northeast Georgia Physicians Group Urgent Care LLC	GA	Family Medicine Physician	$0	$1.6M
Timothy Carey	GA	Medical Oncology Physician	$1.5M	$0
Gainesville Surg Ctr LP	GA	Ambulatory Surgical Clinic/Center	$1.4M	$0
Gainesville Eye Center, LLC	GA	Ambulatory Surgical Clinic/Center	$1.4M	$0

Marta Bognar — Billing Profile & Reimbursement Data

Sign up for Marta Bognar — Billing Profile & Reimbursement Data policy alerts

Marta Bognar — Billing Profile & Reimbursement Data

Sign up for Marta Bognar — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References